CEO of Novo Nordisk on potential successors: "I've only just begun"

At the start of 2022, Lars Fruergaard Jørgensen enters his fifth year as CEO of Novo Nordisk. While talent is being nurtured in the organization, his successor might have a long time to wait.
Lars Fruergaard Jørgensen, CEO of Novo Nordisk | Photo: Stine Bidstrup/ERH
Lars Fruergaard Jørgensen, CEO of Novo Nordisk | Photo: Stine Bidstrup/ERH
by BENJAMIN WERNER CHRISTENSEN, translated by daniel pedersen

The next-in-line to the throne of Denmark's most valuable company, Novo Nordisk, might not even have made it to the executive management level yet, says its current CEO, Lars Fruergaard Jørgensen.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading